Feb. 8, 2024, 5:47 a.m. | Shulin Li Liqiang Yu Bo Liu Qunwei Lin Jiaxin Huang

cs.CV updates on arXiv.org arxiv.org

At present, the incidence and fatality rate of lung cancer in China rank first among all malignant tumors. Despite the continuous development and improvement of China's medical level, the overall 5-year survival rate of lung cancer patients is still lower than 20% and is staged. A number of studies have confirmed that early diagnosis and treatment of early stage lung cancer is of great significance to improve the prognosis of patients. In recent years, artificial intelligence technology has gradually begun …

ai technology analysis application cancer cancer screening china continuous continuous development cs.ai cs.cv development eess.iv improvement lung cancer medical patients physics.med-ph rate screening survival technology tumors

Lead Developer (AI)

@ Cere Network | San Francisco, US

Research Engineer

@ Allora Labs | Remote

Ecosystem Manager

@ Allora Labs | Remote

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote